UK Consortium Given Go-Ahead For Rapid SARS-CoV-2 Antibody Test In Europe
UK-Rapid Test Consortium claims the CE marked, professional-use test is 99.4% accurate and plans to produce 500,000 tests a month from October and one million a month starting in 2021.
You may also be interested in...
Abingdon Health has announced that a study run in conjunction with the UK Rapid Test Consortium has demonstrated that its AbC-19 test could be an effective tool for testing vaccine efficacy.
Move to new distribution center blamed for "very significant" drop in processing capacity for some IVD products.
While the main role of SARS-CoV-2 antibody testing is currently limited to determining exposure to the virus in populations, the scientific community is working hard to define the neutralizing properties of the antibodies detected, and the duration of the immune response. As a result, antibody testing could be here to stay for the long term for monitoring populations, testing vaccines and selecting patients for trials of a variety of new therapies to treat numerous conditions.